RTW Biotech Opportunities Ltd USD (RTW.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 840.66M |
| Enterprise Value | 995.23M |
| P/E Ratio | 4.1 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 5.38 |
| Price/Book Ratio | 1.25 |
| Enterprise/Revenue | 6.38 |
| Enterprise/EBITDA | 3.68 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 1.59 |
| Operating Margin | 2.02 |
AD
Management Effectiveness
| Return On Assets | 0.23 |
| Return On Equity | 0.36 |
Income Statement
| Revenue | 258.01M |
| Revenue/Share | 0.4 |
| Gross Profit | 250.89M |
| EBITDA | 245.19M |
| Net Income | 245.19M |
| Diluted EPS | 0.63 |
Balance Sheet
| Total Cash | 5.99M |
| Total Cash/Share | 0.02 |
| Total Debt | 160.55M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 0.15 |
| Book Value Per Share | 2.22 |
Price History
| 52-Week Change | 84.29 |
| 52-Week High | 2.64 |
| 52-Week Low | 1.39 |
| Moving Average 50 Days | 2.42 |
| Moving Average 200 Days | 2.18 |
Statistics
| Average Volume | 374,382 |
| Shares Outstanding | 322.42M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
